Kiora Pharmaceuticals

(NASDAQ) KPRX

Current Price$2.46

Market Cap$9.64M

Since IPO (2015)-100%

5 Year-100%

1 Year-26%

1 Month+25%

Kiora Pharmaceuticals Financials at a Glance

Market Cap

$9.64M

Revenue (TTM)

$0.00

Net Income (TTM)

$10.84M

EPS (TTM)

$-2.79

P/E Ratio

-0.88

Dividend

$0.00

Beta (Volatility)

0.83 (Low)

Dividend

$0.00

Beta (Volatility)

0.83 (Low)

Price

$2.46

Volume

7,109

Open

$2.40

Price

$2.46

Volume

7,109

Open

$2.40

Previous Close

$2.46

Daily Range

$2.36 - $2.49

52-Week Range

$1.76 - $4.18

Dividend

$0.00

Beta (Volatility)

0.83 (Low)

Price

$2.46

Volume

7,109

Open

$2.40

Previous Close

$2.46

Daily Range

$2.36 - $2.49

52-Week Range

$1.76 - $4.18

KPRX News

Kiora (KPRX) Q2 Revenue Falls 100%

Motley Fool Markets TeamAug 8, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kiora Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Brian Matthew Strem, PhD

Website

www.kiorapharma.com

Headquarters

Encinitas, UT 84105, US

KPRX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-52%

Return on Capital

-46%

Return on Assets

-45%

Earnings Yield

-1.14%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.64M

Shares Outstanding

3.95M

Volume

7.11K

Avg. Volume

487.96K

Financials (TTM)

Gross Profit

$24.80K

Operating Income

$9.46M

EBITDA

$9.43M

Operating Cash Flow

$9.96M

Capital Expenditure

$110.79K

Free Cash Flow

$10.07M

Cash & ST Invst.

$17.09M

Total Debt

$368.26K

Kiora Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$10.51K

N/A

Gross Margin

0.00%

N/A

Market Cap

$9.64M

N/A

Market Cap/Employee

$803.29K

N/A

Employees

N/A

Net Income

$6.52M

-54.3%

EBITDA

$2.62M

-9.2%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$16.72M

-37.5%

Accounts Receivable

$3.32M

+451.6%

Inventory

$0.00

N/A

Long Term Debt

$203.80K

+502.7%

Short Term Debt

$164.46K

+604.2%

Return on Assets

-44.67%

N/A

Return on Invested Capital

-45.87%

N/A

Free Cash Flow

$2.26M

-2.3%

Operating Cash Flow

$2.18M

+3.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

APVOAptevo Therapeutics Inc.

APVOAptevo Therapeutics Inc.$4.92+1.44%

RNAZTransCode Therapeutics, Inc.

RNAZTransCode Therapeutics, Inc.$7.83-2.25%

INABIN8bio, Inc.

INABIN8bio, Inc.$1.50+2.04%

BCDABioCardia, Inc.

BCDABioCardia, Inc.$1.11-2.63%

PHIOPhio Pharmaceuticals Corp.

PHIOPhio Pharmaceuticals Corp.$1.14-6.56%

CELZCreative Medical Technology Holdings, Inc.

CELZCreative Medical Technology Holdings, Inc.$2.24-0.44%

APREAprea Therapeutics, Inc.

APREAprea Therapeutics, Inc.$0.82+2.26%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About KPRX

What is the current price of Kiora Pharmaceuticals?

Kiora Pharmaceuticals is trading at $2.46 per share.

What is the 52-week range for Kiora Pharmaceuticals?

Over the past 52 weeks, Kiora Pharmaceuticals has traded between $1.76 and $4.18.

How much debt does Kiora Pharmaceuticals have?

As of the most recent reporting period, Kiora Pharmaceuticals reported total debt of $368,259.

How much cash does Kiora Pharmaceuticals have on hand?

Kiora Pharmaceuticals reported $8.70M in cash and cash equivalents in its most recent financial results.

What is Kiora Pharmaceuticals’s dividend yield?

Kiora Pharmaceuticals does not currently have a dividend yield.

Kiora Pharmaceuticals

Kiora Pharmaceuticals Financials at a Glance

KPRX News

Kiora (KPRX) Q2 Revenue Falls 100%

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Kiora Pharmaceuticals

KPRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Kiora Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About KPRX

What is the current price of Kiora Pharmaceuticals?

What is the 52-week range for Kiora Pharmaceuticals?

How much debt does Kiora Pharmaceuticals have?

How much cash does Kiora Pharmaceuticals have on hand?

What is Kiora Pharmaceuticals’s dividend yield?

Premium Investing Services